ArticleJournal for immunotherapy of cancer2022

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.

Xiaoyan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.